Holen Sie sich die Stockscreener-App
4.15
2.47%
0.10
Handel nachbörslich:
4.07
-0.08
-1.93%
Schlusskurs vom Vortag:
$4.05
Offen:
$3.96
24-Stunden-Volumen:
662.66K
Relative Volume:
4.34
Marktkapitalisierung:
$22.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.21M
KGV:
-0.1273
EPS:
-32.6
Netto-Cashflow:
$-16.86M
1W Leistung:
+0.00%
1M Leistung:
+5.06%
6M Leistung:
+3.23%
1J Leistung:
-7.98%
1-Tages-Spanne:
$3.73
$4.25
1-Wochen-Bereich:
$3.73
$4.44
52-Wochen-Spanne:
$3.02
$6.01
Cingulate Inc Stock (CING) Company Profile
Firmenname
Cingulate Inc
Sektor
Branche
Telefon
(913) 942-2300
Adresse
1901 W. 47TH PLACE, KANSAS CITY
Vergleichen Sie CING mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
4.15 | 22.70M | 0 | -21.21M | -16.86M | -32.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | ROTH MKM | Buy |
| 2023-12-22 | Herabstufung | Laidlaw | Buy → Hold |
Cingulate Inc Aktie (CING) Neueste Nachrichten
FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date - Investing.com Australia
Cingulate Inc’s NDA for CTx-1301 Accepted by FDA - TipRanks
Cingulate announces FDA accepted for review the NDA for CTx-1301 - TipRanks
Cingulate Inc FDA Accepts NDA for CTx-1301 for ADHD - TradingView
FDA Accepts Cingulate’s New Drug Application for CTx-1301 - GlobeNewswire
FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date - Stock Titan
Will Cingulate Inc. bounce back from current support2025 Retail Activity & Verified Entry Point Signals - newser.com
Will Cingulate Inc. stock remain a Wall Street favorite2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Why Cingulate Inc. stock could be next big winner2025 Year in Review & Technical Confirmation Trade Alerts - newser.com
Will Cingulate Inc. continue its uptrendWeekly Stock Analysis & Daily Stock Trend Reports - newser.com
Can Cingulate Inc. Equity Warrant stock deliver consistent earnings growth2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
What institutional flow reveals about Cingulate Inc.Earnings Recap Report & Low Risk Entry Point Tips - newser.com
How Cingulate Inc. Equity Warrant stock trades before earningsWatch List & Daily Market Momentum Tracking - newser.com
How supply chain issues affect Cingulate Inc. stockOil Prices & Consistent Growth Equity Picks - newser.com
Backtesting results for Cingulate Inc. Equity Warrant trading strategiesOil Prices & Consistent Growth Equity Picks - newser.com
Can Cingulate Inc. stock deliver consistent earnings growthTrade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
Is it too late to sell Cingulate Inc.Quarterly Growth Report & AI Forecast for Swing Trade Picks - newser.com
Is Cingulate Inc a good long term investmentREITs Market Trends & Rapid Portfolio Strategies - earlytimes.in
Cingulate Inc. (NASDAQ:CING) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Is Cingulate Inc. stock entering bullish territoryCEO Change & Smart Money Movement Alerts - newser.com
What’s next for Cingulate Inc. stock priceWeekly Earnings Recap & Fast Entry Momentum Alerts - newser.com
Analyzing drawdowns of Cingulate Inc. Equity Warrant with statistical tools2025 Year in Review & Stock Timing and Entry Methods - newser.com
How Cingulate Inc. stock compares to industry benchmarksQuarterly Trade Summary & Weekly Top Gainers Trade List - newser.com
Market reaction to Cingulate Inc.’s recent newsDividend Hike & Consistent Income Trade Ideas - newser.com
Is Cingulate Inc. a candidate for recovery playInsider Selling & Weekly Chart Analysis and Guides - newser.com
Is Cingulate Inc. stock bottoming outJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com
Cingulate Inc. stock retracement – recovery analysisTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
What does recent volatility data suggest for Cingulate Inc.Trade Analysis Report & Verified Swing Trading Watchlist - newser.com
Using flow based indicators on Cingulate Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Will Cingulate Inc. stock gain from government policiesJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Understanding Cingulate Inc. Equity Warrant’s price movementQuarterly Profit Summary & Precise Buy Zone Identification - newser.com
Real time breakdown of Cingulate Inc. Equity Warrant stock performanceJuly 2025 Retail & Technical Confirmation Trade Alerts - newser.com
Tools to monitor Cingulate Inc. Equity Warrant recovery probability - newser.com
What drives Cingulate Inc Equity Warrant stock priceSupport Zone Identification & The Smart Money Is Buying These Picks - earlytimes.in
Torrent Pharmaceuticals Limited (500420) Hits 52 Week HighMomentum Trading Signals & Low Risk Wealth Plans - earlytimes.in
Can trapped investors hope for a rebound in Cingulate Inc.Insider Buying & Safe Capital Allocation Plans - newser.com
Finanzdaten der Cingulate Inc-Aktie (CING)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):